MG

Meenakshi Gupta

Active Director Director DIN 07248722
DIN 07248722 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 10 active board seats
Past companies 6 historical roles
Total affiliations 16 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 17 Aug 2015
Active appointments 13
Total timeline records 16

Meenakshi Gupta (DIN 07248722) has 16 recorded board appointments in Indian companies, the first from August 2015, of which 13 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2015
Mks Healthcare Private Limited Director · 2025 – present
Current
Torrvis Lifesciences Private Limited Director · 2023 – present
Current
Skymap Lifesciences Private Limited Director · 2022 – present
Current
Skymap Packaging Private Limited Director · 2022 – present
Current
Current
Torrvis Pharmaceuticals Private Limited Director · 2020 – present
Current
Organic Secrets Private Limited Director · 2020 – present
Current
Skymap Welfare Foundation Director · 2019 – present
Current
Manek Tradex Private Limited Director · 2018 – present
Current
Nortis Infrastructure Private Limited Director · 2017 – present
Current
Nortis Lifesciences Llp Designated Partner · 2017 – present
Current
Mks Healthcare Llp Designated Partner · 2015 – present
Current
Mks Pharma Limited Director · 2015 – present
Current
Nortis Lifesciences Private Limited Director · 2025 – 2025
Previous
Skymap Healthcare Private Limited Director · 2015 – 2019
Previous
Cosmax Pharma Llp Designated Partner · 2015 – 2017
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available